ATLASATLAS fair value
ZAR 149.15
Close to fair value · 8% premium
Range: ZAR 89–ZAR 250Fair valuePrice
Aspen Pharmacare (APN.JSE)
Aspen Pharmacare share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Johannesburg Stock Exchange · South Africa
ZAR 160.47▲ +0.79%
Prices as of Oct 27, 2026 · ZAR
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Aspen Pharmacare in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Aspen Pharmacare
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Aspen Pharmacare's fair value at about ZAR 149.15 per share (reasonable range: ZAR 89.02 to ZAR 249.89). At ZAR 160.47, the stock trades within 8% of that figure: close to fair value.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Aspen Pharmacare a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ZAR 151.19 and ZAR 170.57; in 9 out of 10, between ZAR 135.86 and ZAR 189.81. Estimated annual volatility is 33%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ZAR 69.5B
- Market cap (USD)
- $4.2B
- Dividend yield
- 0.01%
- 52-week high
- ZAR 166.21
- 52-week low
- ZAR 90.70
- Gross margin
- 42.4%
- Operating margin
- 19.3%
- Net margin
- 7.6%
- Beta
- 0.52
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Aspen Pharmacare sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks APN.JSE has traded between ZAR 90.70 and ZAR 166.21. Today it is 3.5% below that high and 77% above its low.
Its beta is 0.52: it tends to move less than the market.
About the company
Aspen Pharmacare Holdings Limited, together with its subsidiaries, operates as a specialty and branded pharmaceutical company in Africa, the Middle East, Europe, CIS, Australasia, Asia, and the Americas. It operates through Commercial Pharmaceuticals and Manufacturing segments.
Want to see everything about Aspen Pharmacare?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Aspen Pharmacare (APN.JSE) fair value?
About ZAR 149.15 per share according to ATLAS (reasonable range: ZAR 89.02 to ZAR 249.89). With the stock at ZAR 160.47, it is close to that value.
What is the chance APN.JSE goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, APN.JSE ends the month between ZAR 151.19 and ZAR 170.57.
How big is Aspen Pharmacare and what is its P/E ratio?
Aspen Pharmacare's market capitalization is ZAR 69.5B. We do not show a P/E because it has no positive earnings to base one on.
Does Aspen Pharmacare pay a dividend?
Yes. APN.JSE's current dividend yield is 0.01% at today's price (ZAR 160.47).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer